Luceome Biotechnologies is an emerging, privately-held biotechnology company located in Tucson, Arizona. Luceome enables drug discovery by leveraging its assay technology for identification of drugs against kinases.
Luceome provides unique assay solutions (KinaseSeeker™ and KinaseLite™) to clients for meeting their selectivity profiling needs as well as for the development of assays against specific targets. Luceome’s assays are based on a technology platform that utilizes luciferase fragment complementation. The resulting luminescence detection is sensitive with low background interference, allowing identification of target and off-target effects of drug candidates.
Available Screening Options:
Available Kinase Panels:
Available Screening Options:
Available Kinase Panels:
Available Screening Options:
Available Kinase Panels:
Luceome provides a custom kinase assay development service to clients who wish to use the luciferase fragment complementation assay for screening inhibitors in-house. We will tailor the assay to fit your profiling needs. Contact us for an initial Feasibility Assessment.
Compound Profiling Against Kinases
Available Screening Options:
Available Kinase Panels:
Available Screening Options:
Available Kinase Panels:
Features and Benefits
Features and Benefits
Features and Benefits
Features and Benefits
Features and Benefits
Features and Benefits
Features and Benefits
Available Screening Options:
Available Kinase Panels:
Luceome Biotechnologies has not received any reviews.
Luceome Biotechnologies has not received any endorsements.